Ostrom QT et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol 24:v1–v95. https://doi.org/10.1093/neuonc/noac202
Article CAS PubMed PubMed Central Google Scholar
Tabouret E et al (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32:4655–4662
Vogelbaum MA et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492–516. https://doi.org/10.1200/JCO.21.02314
Article CAS PubMed Google Scholar
Lin X, DeAngelis LM (2015) Treatment of brain metastases. J Clin Oncol 33:3475–3484. https://doi.org/10.1200/JCO.2015.60.9503
Article CAS PubMed PubMed Central Google Scholar
Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20:26–41. https://doi.org/10.1038/s41568-019-0205-x
Article CAS PubMed Google Scholar
van den Bent MJ et al (2023) Primary brain tumours in adults. Lancet. https://doi.org/10.1016/S0140-6736(23)01054-1
Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725–1731. https://doi.org/10.1016/0360-3016(79)90553-4
Article CAS PubMed Google Scholar
Cabrera AR et al (2016) Radiation therapy for glioblastoma: executive summary of an american society for radiation oncology evidence-based clinical practice guideline. Pract Radiat Oncol 6:217–225. https://doi.org/10.1016/j.prro.2016.03.007
Gondi V et al (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 12:265–282. https://doi.org/10.1016/j.prro.2022.02.003
Minniti G, Niyazi M, Alongi F, Navarria P, Belka C (2021) Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol 16:36. https://doi.org/10.1186/s13014-021-01767-9
Article PubMed PubMed Central Google Scholar
Shi W et al (2018) Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: a secondary analysis of NRG oncology/radiation therapy oncology group trial 0525. Int J Radiat Oncol Biol Phys 100:38–44. https://doi.org/10.1016/j.ijrobp.2017.08.038
Tsien CI et al (2023) NRG Oncology/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol 41:1285–1295. https://doi.org/10.1200/JCO.22.00164
Article CAS PubMed Google Scholar
Amberger-Murphy V (2009) Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9:381–390. https://doi.org/10.2174/156800909788166637
Article CAS PubMed Google Scholar
Kabakov AE, Yakimova AO (2021) Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers (Basel) 13(5):1102. https://doi.org/10.3390/cancers13051102
Article CAS PubMed Google Scholar
Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122. https://doi.org/10.1016/0360-3016(91)90171-y
Article CAS PubMed Google Scholar
Lawrence YR et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–27. https://doi.org/10.1016/j.ijrobp.2009.02.091
Article PubMed PubMed Central Google Scholar
Greene-Schloesser D et al (2012) Radiation-induced brain injury: a review. Front Oncol 2:73. https://doi.org/10.3389/fonc.2012.00073
Article CAS PubMed PubMed Central Google Scholar
Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N (2013) Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 169:103–111. https://doi.org/10.1016/j.jconrel.2013.04.007
Article CAS PubMed PubMed Central Google Scholar
Kovacs Z et al (2014) Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release 187:74–82. https://doi.org/10.1016/j.jconrel.2014.05.033
Article CAS PubMed Google Scholar
Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N (2017) Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release 250:77–85. https://doi.org/10.1016/j.jconrel.2016.10.011
Article CAS PubMed Google Scholar
Treat LH et al (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901–907. https://doi.org/10.1002/ijc.22732
Article CAS PubMed Google Scholar
Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38:1716–1725. https://doi.org/10.1016/j.ultrasmedbio.2012.04.015
Article PubMed PubMed Central Google Scholar
Wei KC et al (2013) Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS ONE 8:e58995. https://doi.org/10.1371/journal.pone.0058995
Article CAS PubMed PubMed Central Google Scholar
Chen KT et al (2021) Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors. Sci Adv. https://doi.org/10.1126/sciadv.abd0772
Article PubMed PubMed Central Google Scholar
Chen KT, Wei KC, Liu HL (2019) Theranostic strategy of focused ultrasound induced blood-brain barrier opening for CNS disease treatment. Front Pharmacol 10:86. https://doi.org/10.3389/fphar.2019.00086
Article CAS PubMed PubMed Central Google Scholar
Meng Y, Hynynen K, Lipsman N (2021) Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat Rev Neurol 17:7–22. https://doi.org/10.1038/s41582-020-00418-z
Chen KT, Wei KC, Liu HL (2021) Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics 13(7):1084. https://doi.org/10.3390/pharmaceutics13071084
Article PubMed PubMed Central Google Scholar
Park SH et al (2020) Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg 134:475–483. https://doi.org/10.3171/2019.10.JNS192206
Carpentier A et al (2016) Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med 8:343re342. https://doi.org/10.1126/scitranslmed.aaf6086
Meng Y et al (2021) MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Sci Transl Med 13:eabj4011. https://doi.org/10.1126/scitranslmed.abj4011
Article CAS PubMed Google Scholar
Lin WH, Fan CH, Ting CY, Liu HL, Yeh CK (2013) Dynamic perfusion assessment by contrast-enhanced ultrasound in blood-brain barrier disruption. Annu Int Conf IEEE Eng Med Biol Soc 1152–1155:2013. https://doi.org/10.1109/EMBC.2013.6609710
Morishita K et al (2014) Effects of therapeutic ultrasound on intramuscular blood circulation and oxygen dynamics. J Jpn Phys Ther Assoc 17:1–7. https://doi.org/10.1298/jjpta.Vol17_001
Article PubMed PubMed Central Google Scholar
Wen PY et al (2023) RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. https://doi.org/10.1200/JCO.23.01059
Wen PY et al (2020) Glioblastoma in adults: a society for neuro-oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073–1113. https://doi.org/10.1093/neuonc/noaa106
Article CAS PubMed PubMed Central Google Scholar
Bentzen SM et al (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76:S3–9. https://doi.org/10.1016/j.ijrobp.2009.09.040
Comments (0)